Article

Percutaneous cervical nucleoplasty using coblation technology. Clinical results in fifty consecutive cases.

Policlinico Casilino, UOC Neurochirurgia, Roma, Italy.
Acta neurochirurgica. Supplement 02/2005; 92:73-8.
Source: PubMed

ABSTRACT Conventional open cervical discectomy, with or without bony fusion, in common neurosurgical knowledge is considered the standard treatment for cervical disc herniation. Percutaneous procedures are minimally invasive and offer decreased morbidity, require no bone graft and promise shorter recuperation time. Nevertheless, candidates for a percutaneous procedure as inclusion criteria must complain of symptoms related to contained herniated disc or focal protrusion. It does not substitute conventional open procedures required for extruded discs. We used the coblation technology for nucleoplasty of the cervical intervertebral discs. Early and long-term effects and/or complications observed with this procedure have not been reported yet. Fifty consecutive patients presenting with contained herniated cervical disc or focal protrusion causing compression of the cervical roots or cervical pain underwent a nucleoplasty procedure on the pathological disc. A randomized control group of twenty patients was treated conservatively with medical and physical therapy in the same period and completed the identical follow-up form. In the nucleoplasty group results were complete resolution of symptoms in 80% of cases, only 10% referred some residual cervical or radicular pain and are still under follow-up with a wait-and-see prospective. Patients who did not have a clinical resolution were treated with alternative traditional methods (10%). Despite the relative low cases number and the limited follow-up the encouraging results induce us to utilize this technique in well-selected cases.

0 Bookmarks
 · 
54 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Although percutaneous cervical nucleoplasty (PCN) has been shown to be both safe and effective, its application is still debated. PCN applied in disk herniation has not been systematically reviewed before, resulting in a limited insight into its effectiveness and safety, and the quality of available evidence. Therefore, we systematically reviewed the evidence on the efficacy and safety of PCN in patients with a (contained) herniated disk. MEDLINE, EMBASE, and the Cochrane Library (Central Register of Controlled Trials) were searched for randomized controlled trials (RCTs) and nonrandomized studies using the following keywords: "Nucleoplasty," "Cervical," "Hernia," "Herniation," "Prolapse," "Protrusion," "Intervertebral disk," and "Percutaneous disk decompression." First, all articles were appraised for methodological quality, and then, RCTs were graded for the level of evidence according a best-evidence synthesis, because a meta-analysis was not possible. Finally, the RCTs' applicability and clinical relevance also was assessed. Of 75 identified abstracts, 10 full-text articles were included (3 RCTs and 7 nonrandomized studies). These studies represented a total of 1021 patients: 823 patients (≥ 892 disks) were treated by PCN. All studies showed low methodological quality, except for two. The level of evidence of the RCTs was graded as moderate, with low to moderate applicability and clinical relevance. All included studies showed PCN to be an effective and safe procedure in the treatment of (contained) herniated disks at short-, mid-, and long-term follow-up. However, the level of evidence is moderate and shows only low to moderate applicability and clinical relevance.
    Pain Practice 10/2013; · 2.61 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Clinical study of percutaneous endoscopic surgery for cervical intervertebral disc herniation (CHIVD). Our aim was to evaluate the efficacy of anterior percutaneous endoscopic cervical discectomy (APECD), previously known as percutaneous endoscopic cervical discectomy, for CHIVD. In addition, the ways to avoid major complications, including case selection and surgical techniques, are highlighted. CHIVD is a common disease and can cause cervical radiculopathy, namely, radiating arm pain, numbness or weakness of the upper extremity, or myelopathy. If conservative treatment failed, most patients were treated by anterior cervical discectomy and fusion. From October 2002 to July 2008, a total of 107 consecutive patients with clinically symptomatic CHIVD who underwent APECD were enrolled. The clinical outcomes were evaluated using the visual analog scale, Neck Disability Index, and modified MacNab criteria. Radiographic follow-up included static and dynamic plain cervical radiographs and magnetic resonance imaging. Eighty-six patients (80%) could be followed up for at least 12 months (range: 12 to 60 mo; mean, 22.4 mo) for outcome evaluation. The visual analog scale and Neck Disability Index improved significantly (P<0.001) after the operation. According to the modified MacNab criteria, excellent and good outcome were achieved in 29 (34%) and 49 (57%) patients, respectively. Two patients (2 of 107, 2%) experienced operation-related complications: 1 patient sustained carotid artery injury and was treated with angiographic stenting, whereas the other patient had postoperative headache and recovered after conservative treatment. APECD is not only minimally invasive but can also avoid the morbidities of conventional open cervical discectomy. Patients have a more rapid postoperative recuperation. Nevertheless, it carries the risk of major complications. With careful patient selection and use of meticulous surgical techniques, it is still a safe and effective alternative to open surgical modalities for CHIVD.
    Journal of spinal disorders & techniques 03/2011; 24(7):421-31. · 1.21 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: Percutaneous cervical nucleoplasty (PCN) is a safe and effective treatment in symptomatic patients with contained cervical herniated disks. It provides simple and efficient disk decompression, using a controlled and highly localized ablation, but evidence regarding long-term efficacy is limited. We conducted a retrospective study to investigate the long-term efficacy and safety of PCN, and the influence of ideal selection settings. METHODS: A total of 27 patients treated with PCN fulfilling ideal selection criteria (Group A) were studied and compared to 42 patients not meeting these criteria (Group B). Outcomes were assessed using the Visual Analogue Scale (VAS) and a four-level Likert item for perceived pain and satisfaction, the Neck Disability Index (NDI), and the Short Form 36 (SF-36). Additional relevant outcomes were retrieved from medical records. RESULTS: The postoperative mean VAS pain for Group A was 29.9 (SD ± 32.6) at a mean follow-up of 24 months (range: 2-45). Only 10% of these patients reported mild transient adverse events. There was a trend, but no difference between both groups in pain scores; however, treatment satisfaction was higher for Group A (74.1 ± 27.2-55.5 ± 31.4, P = 0.02). Group A also reported better physical functioning based on the Physical Component Summary (43.6 ± 10.6-37.3 ± 12.0, P = 0.03) and showed a larger proportion of patients no longer using any medication postoperatively (63-26%, P = 0.01). CONCLUSION: These results show long-term effectiveness and safety of PCN in patients with a one-level contained cervical herniated disk, and the reliance of selecting patients meeting ideal criteria for successful PCN.
    Pain Practice 10/2012; · 2.61 Impact Factor